Brennan Kevin M. (CIK 0001971303)

Latest company ownership

XLO - Xilio Therapeutics, Inc.
Role: SVP, FINANCE AND ACCOUNTING
Shares held
20,000
Last filed at
Nov 25, 2025
Confidence Score
49.6
2025Q4
Confidence Score History
2025Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 1, 2025 Jan 3, 2025 Xilio Therapeutics, Inc. SVP, FINANCE AND ACCOUNTING Sell 15.0 -1,803 -36.06% ✓ $1.8K